Les Monts-de-Corsier, Switzerland

Nora Schneider

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nora Schneider: Innovator in Human Milk Oligosaccharides

Introduction

Nora Schneider is a prominent inventor based in Les Monts-de-Corsier, Switzerland. She has made significant contributions to the field of nutrition and cognitive function through her innovative research on human milk oligosaccharides (HMOs). Her work focuses on enhancing executive function in non-infants, showcasing the potential of HMOs in improving brain health.

Latest Patents

Nora Schneider holds a patent for her groundbreaking invention titled "Human milk oligosaccharides for use in enhancing executive function." This patent outlines the use of HMOs or nutritional compositions containing HMOs to enhance executive function in non-infants. The invention aims to prevent and reduce the risk of sub-optimal executive function, manage sub-optimal executive functioning, and improve myelination in the pre-frontal cortex region of the brain. The patent also includes synthetic compositions of HMOs and packs containing at least 14 individual daily doses of an effective amount of at least one HMO for these purposes.

Career Highlights

Nora Schneider is associated with Glycom A/S, a company dedicated to advancing the science of human milk oligosaccharides. Her work at Glycom has positioned her as a leader in the field, contributing to the understanding of how HMOs can benefit cognitive health.

Collaborations

Nora collaborates with notable colleagues, including Bruce McConnell and Louise Kristine Vigsnæs. Their combined expertise enhances the research and development efforts at Glycom, driving innovation in the application of HMOs.

Conclusion

Nora Schneider's contributions to the field of human milk oligosaccharides represent a significant advancement in nutritional science and cognitive health. Her innovative patent and work at Glycom A/S highlight the potential of HMOs in enhancing executive function and improving brain health in non-infants.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…